- Home
- LGND vs PAGP Comparison
LGND vs PAGP Comparison
Compare LGND & PAGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- PAGP
- Stock Information
- Founded
- LGND 1987
- PAGP 2013
- Country
- LGND United States
- PAGP United States
- Employees
- LGND 68
- PAGP N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- PAGP Natural Gas Distribution
- Sector
- LGND Health Care
- PAGP Energy
- Exchange
- LGND Nasdaq
- PAGP Nasdaq
- Market Cap
- LGND 3.2B
- PAGP 3.6B
- IPO Year
- LGND 1992
- PAGP 2013
- Fundamental
- Price
- LGND $184.49
- PAGP $17.62
- Analyst Decision
- LGND Strong Buy
- PAGP Hold
- Analyst Count
- LGND 8
- PAGP 8
- Target Price
- LGND $144.71
- PAGP $20.14
- AVG Volume (30 Days)
- LGND 139.7K
- PAGP 1.0M
- Earning Date
- LGND 08-05-2025
- PAGP 11-05-2025
- Dividend Yield
- LGND N/A
- PAGP 8.64%
- EPS Growth
- LGND N/A
- PAGP N/A
- EPS
- LGND N/A
- PAGP 0.69
- Revenue
- LGND $181,488,000.00
- PAGP $47,796,000,000.00
- Revenue This Year
- LGND $18.41
- PAGP N/A
- Revenue Next Year
- LGND $18.87
- PAGP $12.64
- P/E Ratio
- LGND N/A
- PAGP $25.56
- Revenue Growth
- LGND 53.40
- PAGP N/A
- 52 Week Low
- LGND $81.74
- PAGP $16.61
- 52 Week High
- LGND $129.90
- PAGP $22.31
- Technical
- Relative Strength Index (RSI)
- LGND 79.42
- PAGP 35.76
- Support Level
- LGND $179.40
- PAGP $17.64
- Resistance Level
- LGND $184.26
- PAGP $19.04
- Average True Range (ATR)
- LGND 4.60
- PAGP 0.27
- MACD
- LGND 0.44
- PAGP -0.06
- Stochastic Oscillator
- LGND 100.00
- PAGP 15.05
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests
Plains GP Holdings LP provides transportation, storage, processing, fractionation, and marketing services for crude oil, refined products, natural gas liquids, liquefied petroleum gas, and related products. The group manages its operations through two operating segments: Crude Oil and NGL.